Skip to main content
. Author manuscript; available in PMC: 2013 Oct 8.
Published in final edited form as: J Pharmacol Sci. 2013 Jun 22;122(3):176–183. doi: 10.1254/jphs.12291fp

Fig. 5.

Fig. 5

Effects of Ang II on caspase 3 activity. Podocytes were treated with 100 nmol/L of Ang II for 18 h prior to caspase 3 assay. Data are reported as the mean ± S.E.M. (n = 6), expressed as fold change compared with unstimulated cells. *P < 0.05 vs. control podocytes, **P < 0.05 vs. Ang II alone.